EDIT vs PG
Editas Medicine Inc (EDIT) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
EDIT currently screens at market cap $375.2M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the EDIT and PG stock pages for the full models.
Not investment advice.